This pipeline computes the correlation between significant arm-level copy number variations (cnvs) and selected clinical features.
Testing the association between copy number variation 80 arm-level events and 7 clinical features across 505 patients, 77 significant findings detected with Q value < 0.25.
-
1p gain cnv correlated to 'HISTOLOGICAL.TYPE'.
-
2p gain cnv correlated to 'HISTOLOGICAL.TYPE'.
-
2q gain cnv correlated to 'HISTOLOGICAL.TYPE'.
-
3q gain cnv correlated to 'HISTOLOGICAL.TYPE'.
-
5p gain cnv correlated to 'HISTOLOGICAL.TYPE'.
-
6p gain cnv correlated to 'HISTOLOGICAL.TYPE'.
-
6q gain cnv correlated to 'HISTOLOGICAL.TYPE'.
-
11p gain cnv correlated to 'HISTOLOGICAL.TYPE'.
-
12p gain cnv correlated to 'HISTOLOGICAL.TYPE'.
-
13q gain cnv correlated to 'HISTOLOGICAL.TYPE'.
-
14q gain cnv correlated to 'HISTOLOGICAL.TYPE'.
-
17q gain cnv correlated to 'HISTOLOGICAL.TYPE'.
-
18p gain cnv correlated to 'HISTOLOGICAL.TYPE' and 'RACE'.
-
18q gain cnv correlated to 'HISTOLOGICAL.TYPE'.
-
19p gain cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
19q gain cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
20p gain cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
20q gain cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
21q gain cnv correlated to 'HISTOLOGICAL.TYPE'.
-
22q gain cnv correlated to 'HISTOLOGICAL.TYPE'.
-
1p loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
1q loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
3p loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
3q loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
4p loss cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
4q loss cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
5p loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
5q loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
6p loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
6q loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
7p loss cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
7q loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
8p loss cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
8q loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
9p loss cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
9q loss cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
10p loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
10q loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
11p loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
11q loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
12p loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
12q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
13q loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
14q loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
15q loss cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
16p loss cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
16q loss cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
17p loss cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
17q loss cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
18p loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
18q loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
19p loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
19q loss cnv correlated to 'Time to Death' and 'HISTOLOGICAL.TYPE'.
-
21q loss cnv correlated to 'HISTOLOGICAL.TYPE'.
-
22q loss cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
-
xq loss cnv correlated to 'AGE' and 'HISTOLOGICAL.TYPE'.
Clinical Features |
Time to Death |
AGE |
HISTOLOGICAL TYPE |
RADIATIONS RADIATION REGIMENINDICATION |
COMPLETENESS OF RESECTION |
RACE | ETHNICITY | ||
nCNV (%) | nWild-Type | logrank test | Wilcoxon-test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | Fisher's exact test | |
18p gain | 68 (13%) | 437 |
0.0728 (1.00) |
0.0014 (0.664) |
1e-05 (0.00554) |
0.192 (1.00) |
0.017 (1.00) |
0.00035 (0.171) |
0.691 (1.00) |
19p gain | 50 (10%) | 455 |
0.105 (1.00) |
1.24e-06 (0.00069) |
1e-05 (0.00554) |
0.246 (1.00) |
0.727 (1.00) |
0.0699 (1.00) |
1 (1.00) |
19q gain | 50 (10%) | 455 |
0.03 (1.00) |
1.84e-07 (0.000103) |
1e-05 (0.00554) |
1 (1.00) |
0.733 (1.00) |
0.0153 (1.00) |
0.376 (1.00) |
20p gain | 104 (21%) | 401 |
0.0338 (1.00) |
0.000155 (0.0758) |
1e-05 (0.00554) |
0.00193 (0.913) |
0.0912 (1.00) |
0.0732 (1.00) |
1 (1.00) |
20q gain | 121 (24%) | 384 |
0.00418 (1.00) |
1.14e-05 (0.00573) |
1e-05 (0.00554) |
0.00225 (1.00) |
0.0186 (1.00) |
0.0137 (1.00) |
0.501 (1.00) |
4p loss | 90 (18%) | 415 |
0.0244 (1.00) |
0.000157 (0.0766) |
1e-05 (0.00554) |
0.091 (1.00) |
0.392 (1.00) |
0.326 (1.00) |
0.276 (1.00) |
4q loss | 92 (18%) | 413 |
0.0152 (1.00) |
5.93e-05 (0.0292) |
1e-05 (0.00554) |
0.0706 (1.00) |
0.489 (1.00) |
0.177 (1.00) |
1 (1.00) |
7p loss | 41 (8%) | 464 |
0.0413 (1.00) |
5.63e-05 (0.0277) |
1e-05 (0.00554) |
0.277 (1.00) |
0.315 (1.00) |
0.0445 (1.00) |
1 (1.00) |
8p loss | 73 (14%) | 432 |
0.125 (1.00) |
4.51e-05 (0.0225) |
1e-05 (0.00554) |
0.887 (1.00) |
0.365 (1.00) |
0.0557 (1.00) |
0.702 (1.00) |
9p loss | 93 (18%) | 412 |
0.0263 (1.00) |
1.79e-05 (0.009) |
1e-05 (0.00554) |
0.607 (1.00) |
0.0342 (1.00) |
0.65 (1.00) |
1 (1.00) |
9q loss | 111 (22%) | 394 |
0.0365 (1.00) |
5.99e-09 (3.35e-06) |
1e-05 (0.00554) |
0.336 (1.00) |
0.191 (1.00) |
0.249 (1.00) |
0.741 (1.00) |
12q loss | 32 (6%) | 473 |
0.000482 (0.234) |
0.0685 (1.00) |
1e-05 (0.00554) |
0.31 (1.00) |
0.628 (1.00) |
0.405 (1.00) |
0.563 (1.00) |
15q loss | 100 (20%) | 405 |
0.00907 (1.00) |
5.19e-06 (0.00288) |
1e-05 (0.00554) |
0.0445 (1.00) |
0.332 (1.00) |
0.175 (1.00) |
1 (1.00) |
16p loss | 89 (18%) | 416 |
0.0299 (1.00) |
3.21e-05 (0.0161) |
1e-05 (0.00554) |
0.19 (1.00) |
0.0121 (1.00) |
0.104 (1.00) |
0.472 (1.00) |
16q loss | 127 (25%) | 378 |
0.0666 (1.00) |
8.83e-07 (0.000493) |
1e-05 (0.00554) |
0.0846 (1.00) |
0.0262 (1.00) |
0.0344 (1.00) |
1 (1.00) |
17p loss | 116 (23%) | 389 |
0.00551 (1.00) |
4.85e-06 (0.0027) |
1e-05 (0.00554) |
0.408 (1.00) |
0.133 (1.00) |
0.0112 (1.00) |
0.508 (1.00) |
17q loss | 84 (17%) | 421 |
0.0778 (1.00) |
0.000125 (0.0613) |
1e-05 (0.00554) |
0.348 (1.00) |
0.347 (1.00) |
0.305 (1.00) |
0.0495 (1.00) |
19p loss | 54 (11%) | 451 |
0.000485 (0.235) |
0.108 (1.00) |
1e-05 (0.00554) |
0.873 (1.00) |
0.0709 (1.00) |
0.619 (1.00) |
0.154 (1.00) |
19q loss | 52 (10%) | 453 |
0.000444 (0.216) |
0.158 (1.00) |
1e-05 (0.00554) |
0.328 (1.00) |
0.154 (1.00) |
0.386 (1.00) |
0.128 (1.00) |
22q loss | 100 (20%) | 405 |
0.0604 (1.00) |
4.87e-05 (0.0243) |
1e-05 (0.00554) |
0.0445 (1.00) |
0.528 (1.00) |
0.138 (1.00) |
0.16 (1.00) |
xq loss | 65 (13%) | 440 |
0.0132 (1.00) |
0.000367 (0.179) |
1e-05 (0.00554) |
0.101 (1.00) |
0.151 (1.00) |
0.16 (1.00) |
0.0832 (1.00) |
1p gain | 43 (9%) | 462 |
0.00346 (1.00) |
0.125 (1.00) |
1e-05 (0.00554) |
0.0479 (1.00) |
0.048 (1.00) |
0.0885 (1.00) |
1 (1.00) |
2p gain | 87 (17%) | 418 |
0.00238 (1.00) |
0.00728 (1.00) |
1e-05 (0.00554) |
0.356 (1.00) |
0.604 (1.00) |
0.766 (1.00) |
0.136 (1.00) |
2q gain | 71 (14%) | 434 |
0.00613 (1.00) |
0.0601 (1.00) |
1e-05 (0.00554) |
0.251 (1.00) |
0.296 (1.00) |
0.821 (1.00) |
0.229 (1.00) |
3q gain | 74 (15%) | 431 |
0.00258 (1.00) |
0.0122 (1.00) |
1e-05 (0.00554) |
0.4 (1.00) |
0.228 (1.00) |
0.0102 (1.00) |
1 (1.00) |
5p gain | 48 (10%) | 457 |
0.000527 (0.255) |
0.0158 (1.00) |
1e-05 (0.00554) |
0.0407 (1.00) |
0.104 (1.00) |
0.12 (1.00) |
0.376 (1.00) |
6p gain | 73 (14%) | 432 |
0.79 (1.00) |
0.0523 (1.00) |
1e-05 (0.00554) |
0.478 (1.00) |
0.334 (1.00) |
0.0392 (1.00) |
1 (1.00) |
6q gain | 59 (12%) | 446 |
0.91 (1.00) |
0.101 (1.00) |
3e-05 (0.0151) |
0.758 (1.00) |
0.193 (1.00) |
0.00509 (1.00) |
1 (1.00) |
11p gain | 21 (4%) | 484 |
0.0894 (1.00) |
0.142 (1.00) |
5e-05 (0.0248) |
0.808 (1.00) |
0.201 (1.00) |
0.336 (1.00) |
0.428 (1.00) |
12p gain | 65 (13%) | 440 |
0.106 (1.00) |
0.5 (1.00) |
5e-05 (0.0248) |
0.181 (1.00) |
0.672 (1.00) |
0.0372 (1.00) |
0.229 (1.00) |
13q gain | 29 (6%) | 476 |
0.801 (1.00) |
0.00836 (1.00) |
1e-05 (0.00554) |
1 (1.00) |
0.221 (1.00) |
0.311 (1.00) |
1 (1.00) |
14q gain | 36 (7%) | 469 |
0.266 (1.00) |
0.273 (1.00) |
1e-05 (0.00554) |
0.0061 (1.00) |
0.216 (1.00) |
0.356 (1.00) |
1 (1.00) |
17q gain | 28 (6%) | 477 |
0.019 (1.00) |
0.282 (1.00) |
5e-05 (0.0248) |
1 (1.00) |
0.0319 (1.00) |
0.00623 (1.00) |
0.563 (1.00) |
18q gain | 41 (8%) | 464 |
0.00489 (1.00) |
0.0342 (1.00) |
1e-05 (0.00554) |
0.47 (1.00) |
0.00772 (1.00) |
0.237 (1.00) |
1 (1.00) |
21q gain | 35 (7%) | 470 |
0.131 (1.00) |
0.00344 (1.00) |
1e-05 (0.00554) |
0.237 (1.00) |
0.376 (1.00) |
0.195 (1.00) |
1 (1.00) |
22q gain | 29 (6%) | 476 |
0.0497 (1.00) |
0.00292 (1.00) |
1e-05 (0.00554) |
0.831 (1.00) |
0.02 (1.00) |
0.115 (1.00) |
1 (1.00) |
1p loss | 24 (5%) | 481 |
0.742 (1.00) |
0.0631 (1.00) |
1e-05 (0.00554) |
1 (1.00) |
0.00357 (1.00) |
0.721 (1.00) |
1 (1.00) |
1q loss | 14 (3%) | 491 |
0.0768 (1.00) |
0.272 (1.00) |
3e-05 (0.0151) |
0.369 (1.00) |
0.0227 (1.00) |
0.398 (1.00) |
1 (1.00) |
3p loss | 46 (9%) | 459 |
0.146 (1.00) |
0.00709 (1.00) |
1e-05 (0.00554) |
0.729 (1.00) |
0.909 (1.00) |
0.6 (1.00) |
0.62 (1.00) |
3q loss | 29 (6%) | 476 |
0.689 (1.00) |
0.0436 (1.00) |
1e-05 (0.00554) |
0.284 (1.00) |
0.444 (1.00) |
0.115 (1.00) |
1 (1.00) |
5p loss | 50 (10%) | 455 |
0.0153 (1.00) |
0.158 (1.00) |
1e-05 (0.00554) |
0.18 (1.00) |
0.0989 (1.00) |
0.306 (1.00) |
0.12 (1.00) |
5q loss | 69 (14%) | 436 |
0.0137 (1.00) |
0.00132 (0.626) |
1e-05 (0.00554) |
0.562 (1.00) |
0.539 (1.00) |
0.273 (1.00) |
0.0832 (1.00) |
6p loss | 16 (3%) | 489 |
0.679 (1.00) |
0.103 (1.00) |
1e-05 (0.00554) |
0.777 (1.00) |
0.544 (1.00) |
0.706 (1.00) |
0.334 (1.00) |
6q loss | 24 (5%) | 481 |
0.583 (1.00) |
0.171 (1.00) |
1e-05 (0.00554) |
0.817 (1.00) |
0.456 (1.00) |
0.827 (1.00) |
0.47 (1.00) |
7q loss | 40 (8%) | 465 |
0.495 (1.00) |
0.00119 (0.567) |
1e-05 (0.00554) |
0.356 (1.00) |
0.524 (1.00) |
0.241 (1.00) |
1 (1.00) |
8q loss | 23 (5%) | 482 |
0.651 (1.00) |
0.199 (1.00) |
1e-05 (0.00554) |
0.638 (1.00) |
0.528 (1.00) |
0.221 (1.00) |
0.47 (1.00) |
10p loss | 37 (7%) | 468 |
0.195 (1.00) |
0.00968 (1.00) |
1e-05 (0.00554) |
0.337 (1.00) |
0.121 (1.00) |
0.0369 (1.00) |
0.61 (1.00) |
10q loss | 35 (7%) | 470 |
0.401 (1.00) |
0.00621 (1.00) |
1e-05 (0.00554) |
0.237 (1.00) |
0.489 (1.00) |
0.209 (1.00) |
0.611 (1.00) |
11p loss | 68 (13%) | 437 |
0.0136 (1.00) |
0.00109 (0.52) |
1e-05 (0.00554) |
0.028 (1.00) |
0.295 (1.00) |
0.121 (1.00) |
0.691 (1.00) |
11q loss | 66 (13%) | 439 |
0.0281 (1.00) |
0.004 (1.00) |
1e-05 (0.00554) |
0.00275 (1.00) |
0.108 (1.00) |
0.0676 (1.00) |
0.397 (1.00) |
12p loss | 40 (8%) | 465 |
0.00105 (0.501) |
0.0644 (1.00) |
1e-05 (0.00554) |
0.195 (1.00) |
0.0533 (1.00) |
0.393 (1.00) |
1 (1.00) |
13q loss | 83 (16%) | 422 |
0.0339 (1.00) |
0.0214 (1.00) |
1e-05 (0.00554) |
0.0431 (1.00) |
0.461 (1.00) |
0.62 (1.00) |
0.266 (1.00) |
14q loss | 57 (11%) | 448 |
0.0252 (1.00) |
0.00384 (1.00) |
1e-05 (0.00554) |
0.434 (1.00) |
0.693 (1.00) |
0.0102 (1.00) |
0.136 (1.00) |
18p loss | 46 (9%) | 459 |
0.346 (1.00) |
0.0287 (1.00) |
5e-05 (0.0248) |
0.297 (1.00) |
0.165 (1.00) |
0.988 (1.00) |
1 (1.00) |
18q loss | 58 (11%) | 447 |
0.453 (1.00) |
0.0211 (1.00) |
1e-05 (0.00554) |
0.274 (1.00) |
0.184 (1.00) |
0.267 (1.00) |
0.679 (1.00) |
21q loss | 51 (10%) | 454 |
0.0241 (1.00) |
0.00785 (1.00) |
1e-05 (0.00554) |
1 (1.00) |
0.28 (1.00) |
0.339 (1.00) |
1 (1.00) |
1q gain | 173 (34%) | 332 |
0.128 (1.00) |
0.026 (1.00) |
0.637 (1.00) |
0.834 (1.00) |
0.988 (1.00) |
0.692 (1.00) |
0.15 (1.00) |
3p gain | 44 (9%) | 461 |
0.0686 (1.00) |
0.406 (1.00) |
0.00089 (0.428) |
0.0337 (1.00) |
0.347 (1.00) |
0.0157 (1.00) |
1 (1.00) |
4p gain | 14 (3%) | 491 |
0.115 (1.00) |
0.00994 (1.00) |
0.00148 (0.702) |
1 (1.00) |
0.135 (1.00) |
0.0189 (1.00) |
0.282 (1.00) |
4q gain | 8 (2%) | 497 |
0.641 (1.00) |
0.428 (1.00) |
0.0183 (1.00) |
0.69 (1.00) |
0.486 (1.00) |
0.285 (1.00) |
0.136 (1.00) |
5q gain | 18 (4%) | 487 |
0.15 (1.00) |
0.696 (1.00) |
0.00278 (1.00) |
0.422 (1.00) |
0.229 (1.00) |
0.474 (1.00) |
1 (1.00) |
7p gain | 61 (12%) | 444 |
0.0337 (1.00) |
0.187 (1.00) |
0.0678 (1.00) |
0.287 (1.00) |
0.692 (1.00) |
0.868 (1.00) |
1 (1.00) |
7q gain | 57 (11%) | 448 |
0.00104 (0.499) |
0.246 (1.00) |
0.304 (1.00) |
0.159 (1.00) |
0.518 (1.00) |
0.743 (1.00) |
1 (1.00) |
8p gain | 112 (22%) | 393 |
0.0578 (1.00) |
0.0855 (1.00) |
0.749 (1.00) |
0.0721 (1.00) |
0.166 (1.00) |
0.575 (1.00) |
0.741 (1.00) |
8q gain | 146 (29%) | 359 |
0.0112 (1.00) |
0.891 (1.00) |
0.00356 (1.00) |
0.0608 (1.00) |
0.253 (1.00) |
0.81 (1.00) |
0.359 (1.00) |
9p gain | 20 (4%) | 485 |
0.718 (1.00) |
0.979 (1.00) |
0.0736 (1.00) |
0.306 (1.00) |
0.365 (1.00) |
0.44 (1.00) |
0.0104 (1.00) |
9q gain | 7 (1%) | 498 |
0.684 (1.00) |
0.928 (1.00) |
0.201 (1.00) |
0.68 (1.00) |
0.192 (1.00) |
0.0726 (1.00) |
0.168 (1.00) |
10p gain | 110 (22%) | 395 |
0.843 (1.00) |
0.19 (1.00) |
0.726 (1.00) |
0.545 (1.00) |
0.805 (1.00) |
0.187 (1.00) |
0.312 (1.00) |
10q gain | 104 (21%) | 401 |
0.579 (1.00) |
0.693 (1.00) |
0.787 (1.00) |
0.622 (1.00) |
0.33 (1.00) |
0.196 (1.00) |
1 (1.00) |
11q gain | 18 (4%) | 487 |
0.00317 (1.00) |
0.266 (1.00) |
0.0132 (1.00) |
0.79 (1.00) |
0.276 (1.00) |
0.557 (1.00) |
1 (1.00) |
12q gain | 51 (10%) | 454 |
0.106 (1.00) |
0.54 (1.00) |
0.0701 (1.00) |
0.135 (1.00) |
0.567 (1.00) |
0.044 (1.00) |
0.376 (1.00) |
15q gain | 10 (2%) | 495 |
0.00935 (1.00) |
0.421 (1.00) |
0.645 (1.00) |
0.299 (1.00) |
0.103 (1.00) |
0.386 (1.00) |
0.282 (1.00) |
16p gain | 26 (5%) | 479 |
0.536 (1.00) |
0.0209 (1.00) |
0.0187 (1.00) |
0.0717 (1.00) |
0.275 (1.00) |
0.0823 (1.00) |
0.509 (1.00) |
16q gain | 9 (2%) | 496 |
0.948 (1.00) |
0.138 (1.00) |
0.168 (1.00) |
0.455 (1.00) |
0.00082 (0.395) |
0.186 (1.00) |
0.227 (1.00) |
17p gain | 11 (2%) | 494 |
0.906 (1.00) |
0.665 (1.00) |
0.152 (1.00) |
1 (1.00) |
0.204 (1.00) |
0.847 (1.00) |
0.282 (1.00) |
xq gain | 60 (12%) | 445 |
0.00912 (1.00) |
0.287 (1.00) |
0.296 (1.00) |
0.538 (1.00) |
0.232 (1.00) |
1 (1.00) |
1 (1.00) |
2p loss | 11 (2%) | 494 |
0.0326 (1.00) |
0.174 (1.00) |
0.447 (1.00) |
0.0405 (1.00) |
0.106 (1.00) |
0.386 (1.00) |
0.309 (1.00) |
2q loss | 17 (3%) | 488 |
0.00414 (1.00) |
0.0891 (1.00) |
0.337 (1.00) |
0.0509 (1.00) |
0.383 (1.00) |
0.482 (1.00) |
0.428 (1.00) |
20p loss | 16 (3%) | 489 |
0.585 (1.00) |
0.115 (1.00) |
0.00995 (1.00) |
0.0478 (1.00) |
0.137 (1.00) |
0.398 (1.00) |
0.359 (1.00) |
20q loss | 8 (2%) | 497 |
0.277 (1.00) |
0.588 (1.00) |
0.00946 (1.00) |
0.0384 (1.00) |
1 (1.00) |
0.477 (1.00) |
1 (1.00) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
1P GAIN MUTATED | 18 | 2 | 23 |
1P GAIN WILD-TYPE | 362 | 19 | 81 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
2P GAIN MUTATED | 41 | 5 | 41 |
2P GAIN WILD-TYPE | 339 | 16 | 63 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
2Q GAIN MUTATED | 35 | 4 | 32 |
2Q GAIN WILD-TYPE | 345 | 17 | 72 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
3Q GAIN MUTATED | 32 | 4 | 38 |
3Q GAIN WILD-TYPE | 348 | 17 | 66 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
5P GAIN MUTATED | 16 | 3 | 29 |
5P GAIN WILD-TYPE | 364 | 18 | 75 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
6P GAIN MUTATED | 35 | 1 | 37 |
6P GAIN WILD-TYPE | 345 | 20 | 67 |
P value = 3e-05 (Fisher's exact test), Q value = 0.015
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
6Q GAIN MUTATED | 31 | 1 | 27 |
6Q GAIN WILD-TYPE | 349 | 20 | 77 |
P value = 5e-05 (Fisher's exact test), Q value = 0.025
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
11P GAIN MUTATED | 7 | 0 | 14 |
11P GAIN WILD-TYPE | 373 | 21 | 90 |
P value = 5e-05 (Fisher's exact test), Q value = 0.025
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
12P GAIN MUTATED | 34 | 3 | 28 |
12P GAIN WILD-TYPE | 346 | 18 | 76 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
13Q GAIN MUTATED | 8 | 1 | 20 |
13Q GAIN WILD-TYPE | 372 | 20 | 84 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
14Q GAIN MUTATED | 14 | 2 | 20 |
14Q GAIN WILD-TYPE | 366 | 19 | 84 |
P value = 5e-05 (Fisher's exact test), Q value = 0.025
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
17Q GAIN MUTATED | 12 | 0 | 16 |
17Q GAIN WILD-TYPE | 368 | 21 | 88 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
18P GAIN MUTATED | 20 | 5 | 43 |
18P GAIN WILD-TYPE | 360 | 16 | 61 |
P value = 0.00035 (Fisher's exact test), Q value = 0.17
nPatients | AMERICAN INDIAN OR ALASKA NATIVE | ASIAN | BLACK OR AFRICAN AMERICAN | NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | WHITE |
---|---|---|---|---|---|
ALL | 4 | 19 | 90 | 9 | 357 |
18P GAIN MUTATED | 0 | 2 | 26 | 1 | 35 |
18P GAIN WILD-TYPE | 4 | 17 | 64 | 8 | 322 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
18Q GAIN MUTATED | 15 | 4 | 22 |
18Q GAIN WILD-TYPE | 365 | 17 | 82 |
P value = 1.24e-06 (Wilcoxon-test), Q value = 0.00069
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
19P GAIN MUTATED | 50 | 70.6 (8.7) |
19P GAIN WILD-TYPE | 454 | 63.1 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
19P GAIN MUTATED | 19 | 3 | 28 |
19P GAIN WILD-TYPE | 361 | 18 | 76 |
P value = 1.84e-07 (Wilcoxon-test), Q value = 1e-04
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
19Q GAIN MUTATED | 50 | 71.1 (8.7) |
19Q GAIN WILD-TYPE | 454 | 63.0 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
19Q GAIN MUTATED | 13 | 3 | 34 |
19Q GAIN WILD-TYPE | 367 | 18 | 70 |
P value = 0.000155 (Wilcoxon-test), Q value = 0.076
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
20P GAIN MUTATED | 104 | 67.3 (10.0) |
20P GAIN WILD-TYPE | 400 | 62.9 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
20P GAIN MUTATED | 45 | 4 | 55 |
20P GAIN WILD-TYPE | 335 | 17 | 49 |
P value = 1.14e-05 (Wilcoxon-test), Q value = 0.0057
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
20Q GAIN MUTATED | 121 | 67.5 (10.0) |
20Q GAIN WILD-TYPE | 383 | 62.7 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
20Q GAIN MUTATED | 52 | 4 | 65 |
20Q GAIN WILD-TYPE | 328 | 17 | 39 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
21Q GAIN MUTATED | 11 | 1 | 23 |
21Q GAIN WILD-TYPE | 369 | 20 | 81 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
22Q GAIN MUTATED | 7 | 1 | 21 |
22Q GAIN WILD-TYPE | 373 | 20 | 83 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
1P LOSS MUTATED | 6 | 3 | 15 |
1P LOSS WILD-TYPE | 374 | 18 | 89 |
P value = 3e-05 (Fisher's exact test), Q value = 0.015
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
1Q LOSS MUTATED | 3 | 2 | 9 |
1Q LOSS WILD-TYPE | 377 | 19 | 95 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
3P LOSS MUTATED | 16 | 6 | 24 |
3P LOSS WILD-TYPE | 364 | 15 | 80 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
3Q LOSS MUTATED | 10 | 2 | 17 |
3Q LOSS WILD-TYPE | 370 | 19 | 87 |
P value = 0.000157 (Wilcoxon-test), Q value = 0.077
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
4P LOSS MUTATED | 90 | 67.8 (9.6) |
4P LOSS WILD-TYPE | 414 | 63.0 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
4P LOSS MUTATED | 29 | 6 | 55 |
4P LOSS WILD-TYPE | 351 | 15 | 49 |
P value = 5.93e-05 (Wilcoxon-test), Q value = 0.029
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
4Q LOSS MUTATED | 92 | 67.9 (9.7) |
4Q LOSS WILD-TYPE | 412 | 62.9 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
4Q LOSS MUTATED | 30 | 7 | 55 |
4Q LOSS WILD-TYPE | 350 | 14 | 49 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
5P LOSS MUTATED | 16 | 1 | 33 |
5P LOSS WILD-TYPE | 364 | 20 | 71 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
5Q LOSS MUTATED | 19 | 4 | 46 |
5Q LOSS WILD-TYPE | 361 | 17 | 58 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
6P LOSS MUTATED | 3 | 1 | 12 |
6P LOSS WILD-TYPE | 377 | 20 | 92 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
6Q LOSS MUTATED | 4 | 1 | 19 |
6Q LOSS WILD-TYPE | 376 | 20 | 85 |
P value = 5.63e-05 (Wilcoxon-test), Q value = 0.028
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
7P LOSS MUTATED | 41 | 69.9 (9.7) |
7P LOSS WILD-TYPE | 463 | 63.3 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
7P LOSS MUTATED | 14 | 2 | 25 |
7P LOSS WILD-TYPE | 366 | 19 | 79 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
7Q LOSS MUTATED | 8 | 2 | 30 |
7Q LOSS WILD-TYPE | 372 | 19 | 74 |
P value = 4.51e-05 (Wilcoxon-test), Q value = 0.023
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
8P LOSS MUTATED | 73 | 68.2 (8.6) |
8P LOSS WILD-TYPE | 431 | 63.1 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
8P LOSS MUTATED | 15 | 4 | 54 |
8P LOSS WILD-TYPE | 365 | 17 | 50 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
8Q LOSS MUTATED | 2 | 1 | 20 |
8Q LOSS WILD-TYPE | 378 | 20 | 84 |
P value = 1.79e-05 (Wilcoxon-test), Q value = 0.009
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
9P LOSS MUTATED | 93 | 67.9 (8.6) |
9P LOSS WILD-TYPE | 411 | 62.9 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
9P LOSS MUTATED | 34 | 8 | 51 |
9P LOSS WILD-TYPE | 346 | 13 | 53 |
P value = 5.99e-09 (Wilcoxon-test), Q value = 3.4e-06
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
9Q LOSS MUTATED | 111 | 69.0 (8.8) |
9Q LOSS WILD-TYPE | 393 | 62.4 (11.4) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
9Q LOSS MUTATED | 46 | 9 | 56 |
9Q LOSS WILD-TYPE | 334 | 12 | 48 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
10P LOSS MUTATED | 9 | 4 | 24 |
10P LOSS WILD-TYPE | 371 | 17 | 80 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
10Q LOSS MUTATED | 12 | 4 | 19 |
10Q LOSS WILD-TYPE | 368 | 17 | 85 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
11P LOSS MUTATED | 25 | 6 | 37 |
11P LOSS WILD-TYPE | 355 | 15 | 67 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
11Q LOSS MUTATED | 22 | 7 | 37 |
11Q LOSS WILD-TYPE | 358 | 14 | 67 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
12P LOSS MUTATED | 13 | 1 | 26 |
12P LOSS WILD-TYPE | 367 | 20 | 78 |
P value = 0.000482 (logrank test), Q value = 0.23
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 503 | 60 | 0.0 - 191.8 (22.8) |
12Q LOSS MUTATED | 32 | 9 | 0.8 - 97.7 (18.5) |
12Q LOSS WILD-TYPE | 471 | 51 | 0.0 - 191.8 (23.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
12Q LOSS MUTATED | 8 | 1 | 23 |
12Q LOSS WILD-TYPE | 372 | 20 | 81 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
13Q LOSS MUTATED | 44 | 5 | 34 |
13Q LOSS WILD-TYPE | 336 | 16 | 70 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
14Q LOSS MUTATED | 19 | 3 | 35 |
14Q LOSS WILD-TYPE | 361 | 18 | 69 |
P value = 5.19e-06 (Wilcoxon-test), Q value = 0.0029
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
15Q LOSS MUTATED | 100 | 68.3 (10.3) |
15Q LOSS WILD-TYPE | 404 | 62.7 (11.2) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
15Q LOSS MUTATED | 35 | 8 | 57 |
15Q LOSS WILD-TYPE | 345 | 13 | 47 |
P value = 3.21e-05 (Wilcoxon-test), Q value = 0.016
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
16P LOSS MUTATED | 89 | 67.9 (9.7) |
16P LOSS WILD-TYPE | 415 | 63.0 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
16P LOSS MUTATED | 31 | 6 | 52 |
16P LOSS WILD-TYPE | 349 | 15 | 52 |
P value = 8.83e-07 (Wilcoxon-test), Q value = 0.00049
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
16Q LOSS MUTATED | 127 | 67.8 (9.4) |
16Q LOSS WILD-TYPE | 377 | 62.5 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
16Q LOSS MUTATED | 51 | 7 | 69 |
16Q LOSS WILD-TYPE | 329 | 14 | 35 |
P value = 4.85e-06 (Wilcoxon-test), Q value = 0.0027
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
17P LOSS MUTATED | 116 | 67.7 (9.1) |
17P LOSS WILD-TYPE | 388 | 62.7 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
17P LOSS MUTATED | 41 | 9 | 66 |
17P LOSS WILD-TYPE | 339 | 12 | 38 |
P value = 0.000125 (Wilcoxon-test), Q value = 0.061
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
17Q LOSS MUTATED | 84 | 67.8 (9.7) |
17Q LOSS WILD-TYPE | 420 | 63.1 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
17Q LOSS MUTATED | 34 | 7 | 43 |
17Q LOSS WILD-TYPE | 346 | 14 | 61 |
P value = 5e-05 (Fisher's exact test), Q value = 0.025
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
18P LOSS MUTATED | 22 | 5 | 19 |
18P LOSS WILD-TYPE | 358 | 16 | 85 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
18Q LOSS MUTATED | 25 | 6 | 27 |
18Q LOSS WILD-TYPE | 355 | 15 | 77 |
P value = 0.000485 (logrank test), Q value = 0.23
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 503 | 60 | 0.0 - 191.8 (22.8) |
19P LOSS MUTATED | 53 | 14 | 0.0 - 116.2 (18.8) |
19P LOSS WILD-TYPE | 450 | 46 | 0.1 - 191.8 (23.1) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
19P LOSS MUTATED | 17 | 4 | 33 |
19P LOSS WILD-TYPE | 363 | 17 | 71 |
P value = 0.000444 (logrank test), Q value = 0.22
nPatients | nDeath | Duration Range (Median), Month | |
---|---|---|---|
ALL | 503 | 60 | 0.0 - 191.8 (22.8) |
19Q LOSS MUTATED | 51 | 14 | 0.0 - 125.4 (18.8) |
19Q LOSS WILD-TYPE | 452 | 46 | 0.1 - 191.8 (23.0) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
19Q LOSS MUTATED | 17 | 4 | 31 |
19Q LOSS WILD-TYPE | 363 | 17 | 73 |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
21Q LOSS MUTATED | 19 | 4 | 28 |
21Q LOSS WILD-TYPE | 361 | 17 | 76 |
P value = 4.87e-05 (Wilcoxon-test), Q value = 0.024
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
22Q LOSS MUTATED | 100 | 67.7 (8.9) |
22Q LOSS WILD-TYPE | 404 | 62.9 (11.5) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
22Q LOSS MUTATED | 41 | 10 | 49 |
22Q LOSS WILD-TYPE | 339 | 11 | 55 |
P value = 0.000367 (Wilcoxon-test), Q value = 0.18
nPatients | Mean (Std.Dev) | |
---|---|---|
ALL | 504 | 63.8 (11.2) |
XQ LOSS MUTATED | 65 | 68.3 (9.6) |
XQ LOSS WILD-TYPE | 439 | 63.2 (11.3) |
P value = 1e-05 (Fisher's exact test), Q value = 0.0055
nPatients | ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA | MIXED SEROUS AND ENDOMETRIOID | SEROUS ENDOMETRIAL ADENOCARCINOMA |
---|---|---|---|
ALL | 380 | 21 | 104 |
XQ LOSS MUTATED | 28 | 3 | 34 |
XQ LOSS WILD-TYPE | 352 | 18 | 70 |
-
Copy number data file = transformed.cor.cli.txt
-
Clinical data file = UCEC-TP.merged_data.txt
-
Number of patients = 505
-
Number of significantly arm-level cnvs = 80
-
Number of selected clinical features = 7
-
Exclude regions that fewer than K tumors have mutations, K = 3
For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R
For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.